Evidence map›Paper›PMID 30679797›Full record

ArticleLeukemia2019

Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors.

Theodoros Moysiadis, Panagiotis Baliakas, Davide Rossi, Mark Catherwood, Jonathan C Strefford, Julio Delgado, Achilles Anagnostopoulos, Chrysoula Belessi, Niki Stavroyianni, Sarka Pospisilova and 6 more

Abstract readComparative StudyLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Theodoros MoysiadisInstitute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
Panagiotis BaliakasDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Davide RossiDivision of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
Mark CatherwoodDepartment of Hemato-Oncology, Belfast City Hospital, Belfast, UK.
Jonathan C StreffordCancer Genomics, Academic Unit of Cancer Sciences, Cancer Research UK Centre and Experimental Cancer Medicine Centre, Faculty of Medicine, University of Southampton, Southampton, UK.ORCID http://orcid.org/0000-0002-0972-2881
Julio DelgadoHematology Department, Hospital Clinic, Barcelona, Spain.ORCID http://orcid.org/0000-0002-5157-4376
Achilles AnagnostopoulosHematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
Chrysoula BelessiHematology Department, Nikea General Hospital, Pireaus, Greece.
Niki StavroyianniHematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
Sarka PospisilovaCentral European Institute of Technology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
David OscierDepartment of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
Gianluca GaidanoDivision of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
Elias CampoHematopathology Section, Laboratory of Pathology, Hospital Clinic of Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain.ORCID http://orcid.org/0000-0001-9850-9793
Richard RosenquistDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Paolo GhiaDivision of experimental Oncology, IRCCS Istituto Scientfico San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.
Kostas StamatopoulosInstitute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece. kostas.stamatopoulos@gmail.com.

Funding

Cancer Research UK 23669
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clonal EvolutionMutationBiomarkers, TumorHumansLeukemia, Lymphocytic, Chronic, B-CellPrognosisReceptors, Antigen, B-CellTime FactorsBiomarkers, TumorReceptors, Antigen, B-Cell

Identifiers

PMID30679797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.